The Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2023, provides comprehensive information on the non alcoholic steatohepatitis biomarkers market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Non Alcoholic Steatohepatitis Biomarkers Market’s Growth:
As per The Business Research Company’s Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2023, the global non-alcoholic steatohepatitis biomarkers market size is expected to grow from $0.88 billion in 2022 to $1.10 billion in 2023 at a compound annual growth rate (CAGR) of 24.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global non-alcoholic steatohepatitis biomarkers market size is expected to grow to $2.54 billion in 2027 at a CAGR of 23.2%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9002&type=smp
Technological advancements are a key trend in gaining popularity in the non-alcoholic steatohepatitis biomarkers market. Major companies operating in the non-alcoholic steatohepatitis biomarkers market are focused on developing innovative solutions to strengthen their position in the market. For instance, in October 2022, GENFIT, a France-based late-stage biopharmaceutical company, and LabCorp, a US-based life sciences company, agreed on a five-year exclusive licensing deal for GENFIT’s NIS4 technology to aid in identifying patients with non-alcoholic-steatohepatitis-at-risk (NASH). NIS4 technology is an innovative, multi-biomarker-based algorithm specifically developed to identify patients with non-alcoholic steatohepatitis (NASH) and significant to advanced fibrosis (F > 2), also referred to as at-risk NASH. As part of the agreement, LabCorp will develop and commercialize a blood-based molecular diagnostic test utilizing NIS4 technology in the United States and Canada, giving widespread access to healthcare professionals.
The non alcoholic steatohepatitis biomarkers market is segmented:
1) By Type: Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types
2) By Disease: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
3) By End Use: Research Institutes And Academics, Diagnostic Centres, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses
North America was the largest region in the non alcoholic steatohepatitis biomarkers market in 2022.
The table of contents in TBRC’s non alcoholic steatohepatitis biomarkers market report includes:
- Executive Summary
- Non-Alcoholic Steatohepatitis Biomarkers Market Characteristics
- Non-Alcoholic Steatohepatitis Biomarkers Market Trends And Strategies
- Non-Alcoholic Steatohepatitis Biomarkers Market – Macro Economic Scenario
- Non-Alcoholic Steatohepatitis Biomarkers Market Size And Growth
- Non-Alcoholic Steatohepatitis Biomarkers Market Segmentation
- Non-Alcoholic Steatohepatitis Biomarkers Market Regional And Country Analysis
.
.
.
- Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Biomarkers Market
- Non-Alcoholic Steatohepatitis Biomarkers Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
